B9VR26
Gene name |
CMLKR1 |
Protein name |
Chemerin-like receptor 1 |
Names |
Chemokine-like receptor 1, CMKLR-1 |
Species |
Bos taurus (Bovine) |
KEGG Pathway |
bta:615411 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for B9VR26
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-B9VR26-F1 | Predicted | AlphaFoldDB |
109 variants for B9VR26
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs432982764 | 5 | D>E | No | EVA | |
| rs451478390 | 13 | Y>* | No | EVA | |
| rs476510594 | 16 | D>Y | No | EVA | |
| rs521899136 | 29 | L>V | No | EVA | |
| rs109244836 | 44 | V>I | No | EVA | |
| rs800798597 | 46 | C>G | No | EVA | |
| rs473651731 | 56 | V>G | No | EVA | |
| rs521494972 | 91 | I>T | No | EVA | |
| rs440860178 | 143 | Q>E | No | EVA | |
| rs459320144 | 147 | S>C | No | EVA | |
| rs471787959 | 152 | Y>C | No | EVA | |
| rs438957326 | 153 | T>P | No | EVA | |
| rs463934783 | 154 | A>P | No | EVA | |
| rs463934783 | 154 | A>S | No | EVA | |
| rs482530529 | 155 | C>F | No | EVA | |
| rs461341379 | 156 | L>R | No | EVA | |
| rs479849098 | 157 | V>F | No | EVA | |
| rs465491753 | 158 | I>F | No | EVA | |
| rs477569869 | 158 | I>M | No | EVA | |
| rs444988584 | 159 | W>G | No | EVA | |
| rs469972227 | 160 | V>F | No | EVA | |
| rs437086679 | 160 | V>G | No | EVA | |
| rs469972227 | 160 | V>L | No | EVA | |
| rs455516601 | 161 | L>R | No | EVA | |
| rs467188340 | 162 | A>S | No | EVA | |
| rs434378938 | 162 | A>V | No | EVA | |
| rs452814974 | 164 | F>S | No | EVA | |
| rs457488069 | 165 | L>F | No | EVA | |
| rs438490483 | 165 | L>W | No | EVA | |
| rs443101301 | 166 | S>I | No | EVA | |
| rs476050744 | 166 | S>R | No | EVA | |
| rs461674580 | 167 | S>P | No | EVA | |
| rs479786041 | 168 | P>R | No | EVA | |
| rs458941749 | 169 | S>A | No | EVA | |
| rs458941749 | 169 | S>P | No | EVA | |
| rs482112090 | 171 | V>A | No | EVA | |
| rs469991443 | 171 | V>F | No | EVA | |
| rs434659754 | 172 | F>C | No | EVA | |
| rs467478413 | 172 | F>I | No | EVA | |
| rs467478413 | 172 | F>L | No | EVA | |
| rs452748865 | 172 | F>L | No | EVA | |
| rs434659754 | 172 | F>S | No | EVA | |
| rs464926468 | 173 | R>G | No | EVA | |
| rs457015536 | 174 | D>A | No | EVA | |
| rs432053382 | 174 | D>Y | No | EVA | |
| rs476033679 | 175 | T>A | No | EVA | |
| rs476033679 | 175 | T>P | No | EVA | |
| rs443024372 | 175 | T>R | No | EVA | |
| rs476033679 | 175 | T>S | No | EVA | |
| rs137130391 | 176 | A>P | No | EVA | |
| rs440745192 | 179 | H>P | No | EVA | |
| rs458929727 | 182 | I>M | No | EVA | |
| rs477496015 | 183 | S>F | No | EVA | |
| rs481589870 | 185 | F>L | No | EVA | |
| rs463042180 | 185 | F>S | No | EVA | |
| rs479465459 | 191 | S>A | No | EVA | |
| rs446744965 | 192 | A>G | No | EVA | |
| rs431995773 | 194 | V>D | No | EVA | |
| rs469023660 | 196 | S>T | No | EVA | |
| rs455081341 | 197 | P>A | No | EVA | |
| rs434258088 | 198 | W>R | No | EVA | |
| rs470988105 | 199 | P>Q | No | EVA | |
| rs452759919 | 199 | P>T | No | EVA | |
| rs462976359 | 200 | A>D | No | EVA | |
| rs462976359 | 200 | A>G | No | EVA | |
| rs442069575 | 201 | H>N | No | EVA | |
| rs460974752 | 201 | H>P | No | EVA | |
| rs479453368 | 201 | H>Q | No | EVA | |
| rs446681957 | 203 | Q>P | No | EVA | |
| rs458808106 | 204 | V>G | No | EVA | |
| rs477361536 | 206 | P>S | No | EVA | |
| rs450364801 | 207 | V>E | No | EVA | |
| rs448231557 | 209 | S>T | No | EVA | |
| rs467152889 | 209 | S>Y | No | EVA | |
| rs434196624 | 210 | G>R | No | EVA | |
| rs471240551 | 215 | V>G | No | EVA | |
| rs438297622 | 216 | T>N | No | EVA | |
| rs456419356 | 219 | R>G | No | EVA | |
| rs474854716 | 220 | F>L | No | EVA | |
| rs442057255 | 222 | C>F | No | EVA | |
| rs460511839 | 224 | F>L | No | EVA | |
| rs444369562 | 228 | G>V | No | EVA | |
| rs481049299 | 230 | I>M | No | EVA | |
| rs448163998 | 231 | T>P | No | EVA | |
| rs466643504 | 232 | T>A | No | EVA | |
| rs466643504 | 232 | T>P | No | EVA | |
| rs478723061 | 233 | A>P | No | EVA | |
| rs478723061 | 233 | A>S | No | EVA | |
| rs446163819 | 234 | C>G | No | EVA | |
| rs446163819 | 234 | C>R | No | EVA | |
| rs464770949 | 237 | T>P | No | EVA | |
| rs438277847 | 237 | T>S | No | EVA | |
| rs456858306 | 238 | I>N | No | EVA | |
| rs468389791 | 240 | Y>D | No | EVA | |
| rs435581572 | 242 | L>M | No | EVA | |
| rs453999319 | 244 | R>C | No | EVA | |
| rs208547841 | 245 | S>T | No | EVA | |
| rs798149456 | 284 | V>M | No | EVA | |
| rs523621836 | 293 | V>M | No | EVA | |
| rs439693211 | 297 | T>P | No | EVA | |
| rs452210376 | 318 | F>L | No | EVA | |
| rs470847712 | 319 | K>N | No | EVA | |
| rs444274657 | 323 | V>G | No | EVA | |
| rs481334237 | 326 | F>C | No | EVA | |
| rs462879230 | 326 | F>L | No | EVA | |
| rs441603699 | 326 | F>L | No | EVA | |
| rs460141134 | 327 | S>P | No | EVA | |
| rs445773220 | 342 | Y>S | No | EVA | |
| rs464718019 | 360 | G>R | No | EVA |
No associated diseases with B9VR26
1 regional properties for B9VR26
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | GPCR, rhodopsin-like, 7TM | 52 - 311 | IPR017452 |
2 GO annotations of cellular component
| Name | Definition |
|---|---|
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| adipokinetic hormone binding | Binding to an adipokinetic hormone. Adipokinetic hormones (AKHs) are peptide hormones that are involved in the mobilization of sugar and lipids from the insect fat body during energy-requiring activities such as flight and locomotion. They also contribute to hemolymph sugar homeostasis. |
| adipokinetic hormone receptor activity | Combining with an adipokinetic hormone to initiate a change in cell activity. Adipokinetic hormones (AKHs) are protein or peptide hormones that are important for sugar and fat homeostasis in metazoa. In insects, they mobilize sugar and lipids from the insect fat body during energy-requiring activities such as flight and locomotion. They also contribute to hemolymph sugar homeostasis. |
| complement receptor activity | Combining with any component or product of the complement cascade and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
| G protein-coupled receptor activity | Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. |
12 GO annotations of biological process
| Name | Definition |
|---|---|
| chemotaxis | The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| complement receptor mediated signaling pathway | The series of molecular signals generated as a consequence of a component of the complement pathway binding to a complement receptor. Such components include both whole complement proteins and fragments of complement proteins generated through the activity of the complement pathway. |
| G protein-coupled receptor signaling pathway | The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane. |
| inflammatory response | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| negative regulation of interleukin-12 production | Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-12 production. |
| negative regulation of NF-kappaB transcription factor activity | Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB. |
| phospholipase C-activating G protein-coupled receptor signaling pathway | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of phospholipase C (PLC) and a subsequent increase in the intracellular concentration of inositol trisphosphate (IP3) and diacylglycerol (DAG). |
| positive regulation of cold-induced thermogenesis | Any process that activates or increases the frequency, rate or extent of cold-induced thermogenesis. |
| positive regulation of cytosolic calcium ion concentration | Any process that increases the concentration of calcium ions in the cytosol. |
| positive regulation of fat cell differentiation | Any process that activates or increases the frequency, rate or extent of adipocyte differentiation. |
| positive regulation of macrophage chemotaxis | Any process that increases the rate, frequency or extent of macrophage chemotaxis. Macrophage chemotaxis is the movement of a macrophage in response to an external stimulus. |
| regulation of calcium-mediated signaling | Any process that modulates the frequency, rate or extent of calcium-mediated signaling, the process in which a cell uses calcium ions to convert an extracellular signal into a response. |
119 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q2YDN1 | GPR161 | G protein-coupled receptor 161 | Bos taurus (Bovine) | PR |
| Q0GBZ5 | HCRTR1 | Orexin/Hypocretin receptor type 1 | Bos taurus (Bovine) | PR |
| Q17QD8 | GPR37L1 | G-protein coupled receptor 37-like 1 | Bos taurus (Bovine) | PR |
| Q8SPN1 | PROKR2 | Prokineticin receptor 2 | Bos taurus (Bovine) | PR |
| P46626 | ADRB3 | Beta-3 adrenergic receptor | Bos taurus (Bovine) | PR |
| O46639 | TRHR | Thyrotropin-releasing hormone receptor | Bos taurus (Bovine) | PR |
| Q8SPN2 | PROKR1 | Prokineticin receptor 1 | Bos taurus (Bovine) | PR |
| P18130 | ADRA1A | Alpha-1A adrenergic receptor | Bos taurus (Bovine) | PR |
| B4XF06 | GPR39 | G-protein coupled receptor 39 | Bos taurus (Bovine) | PR |
| O18913 | OPN1LW | Long-wave-sensitive opsin 1 | Felis catus (Cat) (Felis silvestris catus) | PR |
| P28683 | PRA1 | Green-sensitive opsin | Gallus gallus (Chicken) | PR |
| Q9N298 | HTR1A | 5-hydroxytryptamine receptor 1A | Pan troglodytes (Chimpanzee) | PR |
| P08099 | Rh2 | Opsin Rh2 | Drosophila melanogaster (Fruit fly) | PR |
| P06002 | ninaE | Opsin Rh1 | Drosophila melanogaster (Fruit fly) | PR |
| Q4LBB9 | Octbeta2R | Octopamine receptor beta-2R | Drosophila melanogaster (Fruit fly) | PR |
| Q8NFJ6 | PROKR2 | Prokineticin receptor 2 | Homo sapiens (Human) | PR |
| Q13585 | GPR50 | Melatonin-related receptor | Homo sapiens (Human) | PR |
| Q9BZJ6 | GPR63 | Probable G-protein coupled receptor 63 | Homo sapiens (Human) | PR |
| Q9H3N8 | HRH4 | Histamine H4 receptor | Homo sapiens (Human) | PR |
| P28336 | NMBR | Neuromedin-B receptor | Homo sapiens (Human) | PR |
| Q9Y5Y3 | GPR45 | Probable G-protein coupled receptor 45 | Homo sapiens (Human) | PR |
| P08913 | ADRA2A | Alpha-2A adrenergic receptor | Homo sapiens (Human) | PR |
| P41597 | CCR2 | C-C chemokine receptor type 2 | Homo sapiens (Human) | PR |
| P51681 | CCR5 | C-C chemokine receptor type 5 | Homo sapiens (Human) | PR |
| Q8TCW9 | PROKR1 | Prokineticin receptor 1 | Homo sapiens (Human) | PR |
| P08908 | HTR1A | 5-hydroxytryptamine receptor 1A | Homo sapiens (Human) | PR |
| P30559 | OXTR | Oxytocin receptor | Homo sapiens (Human) | PR |
| P32239 | CCKBR | Gastrin/cholecystokinin type B receptor | Homo sapiens (Human) | PR |
| O60883 | GPR37L1 | G-protein coupled receptor 37-like 1 | Homo sapiens (Human) | PR |
| Q8TDU9 | RXFP4 | Relaxin-3 receptor 2 | Homo sapiens (Human) | PR |
| P04000 | OPN1LW | Long-wave-sensitive opsin 1 | Homo sapiens (Human) | PR |
| Q6U736 | OPN5 | Opsin-5 | Homo sapiens (Human) | PR |
| P34972 | CNR2 | Cannabinoid receptor 2 | Homo sapiens (Human) | PR |
| P24530 | EDNRB | Endothelin receptor type B | Homo sapiens (Human) | PR |
| P35348 | ADRA1A | Alpha-1A adrenergic receptor | Homo sapiens (Human) | PR |
| Q6W5P4 | NPSR1 | Neuropeptide S receptor | Homo sapiens (Human) | PR |
| O43613 | HCRTR1 | Orexin/Hypocretin receptor type 1 | Homo sapiens (Human) | PR |
| P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Homo sapiens (Human) | PR |
| Q9BXC0 | HCAR1 | Hydroxycarboxylic acid receptor 1 | Homo sapiens (Human) | PR |
| P30556 | AGTR1 | Type-1 angiotensin II receptor | Homo sapiens (Human) | PR |
| Q15761 | NPY5R | Neuropeptide Y receptor type 5 | Homo sapiens (Human) | PR |
| Q8N6U8 | GPR161 | G-protein coupled receptor 161 | Homo sapiens (Human) | PR |
| Q6DWJ6 | GPR139 | Probable G-protein coupled receptor 139 | Homo sapiens (Human) | PR |
| P21462 | FPR1 | fMet-Leu-Phe receptor | Homo sapiens (Human) | PR |
| P35414 | APLNR | Apelin receptor | Homo sapiens (Human) | PR |
| P46091 | CMKLR2 | Chemerin-like receptor 2 | Homo sapiens (Human) | PR |
| P32745 | SSTR3 | Somatostatin receptor type 3 | Homo sapiens (Human) | PR |
| P41439 | FOLR3 | Folate receptor gamma | Homo sapiens (Human) | PR |
| Q99788 | CMKLR1 | Chemerin-like receptor 1 | Homo sapiens (Human) | PR |
| P19973 | Lsp1 | Lymphocyte-specific protein 1 | Mus musculus (Mouse) | PR |
| O54799 | Nmbr | Neuromedin-B receptor | Mus musculus (Mouse) | PR |
| Q64264 | Htr1a | 5-hydroxytryptamine receptor 1A | Mus musculus (Mouse) | PR |
| P51675 | Ccr1 | C-C chemokine receptor type 1 | Mus musculus (Mouse) | PR |
| Q5U431 | Gpr39 | G-protein coupled receptor 39 | Mus musculus (Mouse) | PR |
| Q99JG2 | Gpr37l1 | G-protein coupled receptor 37-like 1 | Mus musculus (Mouse) | PR |
| P97295 | Npy2r | Neuropeptide Y receptor type 2 | Mus musculus (Mouse) | PR |
| O08786 | Cckar | Cholecystokinin receptor type A | Mus musculus (Mouse) | PR |
| P56481 | Cckbr | Gastrin/cholecystokinin type B receptor | Mus musculus (Mouse) | PR |
| P30731 | Gpr83 | G-protein coupled receptor 83 | Mus musculus (Mouse) | PR |
| P21761 | Trhr | Thyrotropin-releasing hormone receptor | Mus musculus (Mouse) | PR |
| Q5QD16 | Taar3 | Trace amine-associated receptor 3 | Mus musculus (Mouse) | PR |
| P97292 | Hrh2 | Histamine H2 receptor | Mus musculus (Mouse) | PR |
| Q9EQQ3 | Gpr63 | Probable G-protein coupled receptor 63 | Mus musculus (Mouse) | PR |
| Q924H0 | Npffr2 | Neuropeptide FF receptor 2 | Mus musculus (Mouse) | PR |
| P34971 | Adrb1 | Beta-1 adrenergic receptor | Mus musculus (Mouse) | PR |
| Q91ZY2 | Hrh4 | Histamine H4 receptor | Mus musculus (Mouse) | PR |
| O88416 | Gpr33 | Probable G-protein coupled receptor 33 | Mus musculus (Mouse) | PR |
| Q8K087 | Cmklr2 | Chemerin-like receptor 2 | Mus musculus (Mouse) | PR |
| P70658 | Cxcr4 | C-X-C chemokine receptor type 4 | Mus musculus (Mouse) | PR |
| Q9WV08 | Aplnr | Apelin receptor | Mus musculus (Mouse) | PR |
| P97718 | Adra1a | Alpha-1A adrenergic receptor | Mus musculus (Mouse) | PR |
| Q8BZP8 | Npsr1 | Neuropeptide S receptor | Mus musculus (Mouse) | PR |
| Q8K458 | Prokr2 | Prokineticin receptor 2 | Mus musculus (Mouse) | PR |
| P58308 | Hcrtr2 | Orexin receptor type 2 | Mus musculus (Mouse) | PR |
| Q7TQP3 | Gpr119 | Glucose-dependent insulinotropic receptor | Mus musculus (Mouse) | PR |
| Q8BGE9 | Rxfp3 | Relaxin-3 receptor 1 | Mus musculus (Mouse) | PR |
| Q6VZZ7 | Opn5 | Opsin-5 | Mus musculus (Mouse) | PR |
| Q8CIM5 | Gpr84 | G-protein coupled receptor 84 | Mus musculus (Mouse) | PR |
| P25962 | Adrb3 | Beta-3 adrenergic receptor | Mus musculus (Mouse) | PR |
| Q80UC8 | Gpr139 | Probable G-protein coupled receptor 139 | Mus musculus (Mouse) | PR |
| P0C5I1 | Gpr25 | Probable G-protein coupled receptor 25 | Mus musculus (Mouse) | PR |
| P47936 | Cnr2 | Cannabinoid receptor 2 | Mus musculus (Mouse) | PR |
| Q5QD13 | Taar6 | Trace amine-associated receptor 6 | Mus musculus (Mouse) | PR |
| P35846 | Folr1 | Folate receptor alpha | Mus musculus (Mouse) | PR |
| P58307 | Hcrtr1 | Orexin/Hypocretin receptor type 1 | Mus musculus (Mouse) | PR |
| Q8C131 | Hcar1 | Hydroxycarboxylic acid receptor 1 | Mus musculus (Mouse) | PR |
| Q9EQQ4 | Gpr45 | Probable G-protein coupled receptor 45 | Mus musculus (Mouse) | PR |
| B2RPY5 | Gpr161 | G-protein coupled receptor 161 | Mus musculus (Mouse) | PR |
| P97468 | Cmklr1 | Chemerin-like receptor 1 | Mus musculus (Mouse) | PR |
| Q764M9 | CXCR4 | C-X-C chemokine receptor type 4 | Sus scrofa (Pig) | PR |
| Q9EQD2 | Npffr2 | Neuropeptide FF receptor 2 | Rattus norvegicus (Rat) | PR |
| O08565 | Cxcr4 | C-X-C chemokine receptor type 4 | Rattus norvegicus (Rat) | PR |
| Q01717 | Trhr | Thyrotropin-releasing hormone receptor | Rattus norvegicus (Rat) | PR |
| P30936 | Sstr3 | Somatostatin receptor type 3 | Rattus norvegicus (Rat) | PR |
| Q9JHG3 | Aplnr | Apelin receptor | Rattus norvegicus (Rat) | PR |
| P43140 | Adra1a | Alpha-1A adrenergic receptor | Rattus norvegicus (Rat) | PR |
| P19327 | Htr1a | 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Rat) | PR |
| P56719 | Hcrtr2 | Orexin receptor type 2 | Rattus norvegicus (Rat) | PR |
| P28564 | Htr1b | 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Rat) | PR |
| P56718 | Hcrtr1 | Orexin/Hypocretin receptor type 1 | Rattus norvegicus (Rat) | PR |
| P28647 | Adora3 | Adenosine receptor A3 | Rattus norvegicus (Rat) | PR |
| P25102 | Hrh2 | Histamine H2 receptor | Rattus norvegicus (Rat) | PR |
| P23944 | Adra1d | Alpha-1D adrenergic receptor | Rattus norvegicus (Rat) | PR |
| Q8R415 | Prokr2 | Prokineticin receptor 2 | Rattus norvegicus (Rat) | PR |
| Q5QD24 | Taar3 | Trace amine-associated receptor 3 | Rattus norvegicus (Rat) | PR |
| P0C0W8 | Gpr139 | Probable G-protein coupled receptor 139 | Rattus norvegicus (Rat) | PR |
| P35370 | Oprl1 | Nociceptin receptor | Rattus norvegicus (Rat) | PR |
| P46090 | Cmklr2 | Chemerin-like receptor 2 | Rattus norvegicus (Rat) | PR |
| O97664 | CMKLR2 | Chemerin-like receptor 2 | Macaca mulatta (Rhesus macaque) | PR |
| O97666 | APLNR | Apelin receptor | Macaca mulatta (Rhesus macaque) | PR |
| Q56H79 | NPSR1 | Neuropeptide S receptor | Macaca mulatta (Rhesus macaque) | PR |
| Q18904 | npr-8 | Probable G-protein coupled receptor npr-8 | Caenorhabditis elegans | PR |
| Q09388 | gar-2 | Muscarinic acetylcholine receptor gar-2 | Caenorhabditis elegans | PR |
| B3DM66 | gpr161 | G-protein coupled receptor 161 | Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) | PR |
| Q9W6A6 | opn1mw4 | Green-sensitive opsin-4 | Danio rerio (Zebrafish) (Brachydanio rerio) | PR |
| Q9W6A5 | opn1mw1 | Green-sensitive opsin-1 | Danio rerio (Zebrafish) (Brachydanio rerio) | PR |
| Q8AYM7 | opn1mw3 | Green-sensitive opsin-3 | Danio rerio (Zebrafish) (Brachydanio rerio) | PR |
| Q8AYN0 | opn1lw2 | Red-sensitive opsin-2 | Danio rerio (Zebrafish) (Brachydanio rerio) | PR |
| Q90X46 | gpr161 | G-protein coupled receptor 161 | Danio rerio (Zebrafish) (Brachydanio rerio) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MEAEDYNASY | EDYPDDVDPI | VVLEELSPLE | GRVVRILLVA | VYSVICLLGI | LGNGLVIVMI |
| 70 | 80 | 90 | 100 | 110 | 120 |
| TCKMKRTVNT | VWFLNLAVAD | FLFNVFLPVH | IAYAALDYHW | VFGTAMCKIS | NFLLIHNMFT |
| 130 | 140 | 150 | 160 | 170 | 180 |
| SVFLLTVISF | DRCVSVLLPV | WSQNHRSVRL | AYTACLVIWV | LAFFLSSPSL | VFRDTARLHG |
| 190 | 200 | 210 | 220 | 230 | 240 |
| KISCFNNFSL | SAAVSSPWPA | HPQVDPVGSG | RHKVVTITRF | LCGFLVPGLI | TTACYLTIVY |
| 250 | 260 | 270 | 280 | 290 | 300 |
| KLQRSRLAKT | KKPFKIILTI | IVTFFLCWCP | YHAFYLLELR | RGSVPPSVFS | LGVPLATAIA |
| 310 | 320 | 330 | 340 | 350 | 360 |
| IANSCMNPIL | YVFMGQDFKK | FRVALFSRLV | NALSEDTGHS | SYPSHRSFTK | MSSMNERETG |
| ML |